|
Research Management and Support - Total
|
RMS2012 [E]
|
$374,919,382
|
N/A
|
(NCI)
|
|
COG NCTN Network Group Operations Center
|
5U10CA180886-05
|
$20,853,800
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Quantitative Radiomics System Decoding the Tumor Phenotype
|
5U24CA194354-04
|
$683,694
|
AERTS, HUGO
|
DANA-FARBER CANCER INST
|
|
Targeting SHP2 as a precision medicine for the treatment of HER2-positive breast cancer
|
1R01CA213996-01A1
|
$343,125
|
AGAZIE, YEHENEW
|
WEST VIRGINIA UNIVERSITY
|
|
Functional Determinants of Metastatic Dormancy
|
5R01CA109182-15
|
$423,844
|
AGUIRRE-GHISO, JULIO
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
The role of the SCF/FBW7 ubiquitin ligase complex in hematopiesis and leukemia.
|
5R01CA133379-10
|
$381,375
|
AIFANTIS, IANNIS
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
HER2-pretargeting image-guided therapy of breast cancer
|
5R01CA209884-02
|
$393,896
|
ARTEMOV, DMITRI
|
JOHNS HOPKINS UNIVERSITY
|
|
Targeting the TGIF/Twist1 network in osteosarcoma
|
5R01CA210911-02
|
$348,844
|
ATFI, AZEDDINE
|
UNIVERSITY OF MISSISSIPPI MED CTR
|
|
Behavioral Activation for Smoking Cessation and the Prevention of Post-Cessation Weight Gain
|
5R01CA206058-03
|
$634,518
|
AUDRAIN-MCGOVERN, JANET
|
UNIVERSITY OF PENNSYLVANIA
|
|
Bone Marrow Stem Cells Participation in Solid Organ Cancers Carcinogenesis
|
ZIABC011004
|
$154,897
|
Avital, Itzhak
|
CCR (NCI)
|
|
Clinical Translation of Nuclear Export Inhibitor in Metastatic Pancreatic Cancer
|
1R37CA215427-01A1
|
$352,275
|
AZMI, ASFAR
|
WAYNE STATE UNIVERSITY
|
|
Role of Receptor for Advanced Glycation End Product (RAGE) Pathway in Brain Tumors
|
5R01CA155769-07
|
$410,877
|
BADIE, BEHNAM
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
7T Neurosurgical Mapping Protocol for Endoscopic Resection of Skull Base Tumors
|
5R01CA202911-03
|
$387,731
|
BALCHANDANI, PRITI
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
Functional Significance of CD133 in Pancreatic Cancer
|
5R01CA184274-05
|
$318,513
|
BANERJEE, SULAGNA
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
Metabolic and signaling control of tumorformation in drosophila
|
5R01CA217608-28
|
$352,275
|
BANERJEE, UTPAL
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Functional Inhibition of Deubiquitylase HAUSP to Disrupt Glioblastoma Stem Cells
|
5R01CA184090-04
|
$362,569
|
BAO, SHIDENG
|
CLEVELAND CLINIC LERNER COM-CWRU
|
|
Mapping druggable co-dependency pathways in NRF2-driven lung cancers
|
5K99CA215249-02
|
$114,750
|
BAR-PELED, LIRON
|
SCRIPPS RESEARCH INSTITUTE
|
|
Fundamental subcortical mechanisms of affective processing
|
5U01CA193632-03
|
$350,973
|
BARRETT, LISA
|
NORTHEASTERN UNIVERSITY
|
|
The Role of RHOA in Diffuse Gastric Cancer
|
1R01CA224428-01
|
$677,302
|
BASS, ADAM
|
DANA-FARBER CANCER INST
|
|
MD Anderson Cancer Center EDRN- CVC for Early Detection of Ovarian Cancer
|
5U01CA200462-03
|
$910,580
|
BAST, ROBERT
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Identifying the Molecular and Cellular Basis of Invasive Phenotype in Human DCIS
|
5R01CA207445-02
|
$571,242
|
BEHBOD, FARIBA
|
UNIVERSITY OF KANSAS MEDICAL CENTER
|
|
Dietary fats, mitochondrial function and muscle health in cancer patients
|
1R21CA209566-01A1
|
$199,655
|
BELURY, MARTHA
|
OHIO STATE UNIVERSITY
|
|
Influence of Exercise on Neurocognitive Function in Breast Cancer
|
5R01CA196762-03
|
$607,082
|
BENDER, CATHERINE
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Humanized Anti-Renalase Antibodies for Unresectable Melanoma
|
1R43CA224463-01
|
$299,996
|
BERKOWITZ, BARRY
|
BESSOR PHARMA, LLC
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
5U10CA180821-05
|
$8,073,787
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
BET protein antagonist-based targeted therapy of Mantle Cell Lymphoma
|
5R01CA210250-02
|
$390,134
|
BHALLA, KAPIL
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Reversing/Blocking T cell suppression by extracellular vesicles as cancer therapy
|
1R43CA224602-01A1
|
$280,928
|
BHATTA, MAULASRI
|
IMMUNE MODULATORY THERAPIES, LLC
|
|
Crosstalk of LKB1 and KEAP1 mutations in driving growth of lung adenocarcinoma
|
5R01CA206155-03
|
$395,755
|
BISWAL, SHYAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Improving Physical Functioning in Older Cancer Survivors Through Light-Intensity Physical Activity
|
1K07CA215937-01A1
|
$154,707
|
BLAIR, CINDY
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
Pediatric Oncology Clinical Research Training Program
|
5K12CA090433-17
|
$827,164
|
BLANEY, SUSAN
|
BAYLOR COLLEGE OF MEDICINE
|
|
SWOG Network Group Operations Center of the NCTN
|
5U10CA180888-05
|
$8,625,592
|
BLANKE, CHARLES
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
Virtual Transportation as a Strategy to Reduce Resistance to Cigarette and e-Cigarette Graphic Health Warnings in Adolescents and Young Adults
|
5R01CA214587-03
|
$363,195
|
BLANTON, HART
|
TEXAS A&M UNIVERSITY
|
|
The Breast Cancer and the Workforce Communication App: A randomized controlled trial of an English/Spanish intervention to promote long-term job retention
|
1R37CA214785-01A1
|
$730,499
|
BLINDER, VICTORIA
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Alternatively Spliced Tissue Factor and Pathobiology of Pancreatic Cancer
|
5R01CA190717-04
|
$276,298
|
BOGDANOV, VLADIMIR
|
UNIVERSITY OF CINCINNATI
|
|
A Unique Class of Reductively Activated Oncology Drugs
|
5R01CA208669-02
|
$718,986
|
BOGER, DALE
|
SCRIPPS RESEARCH INSTITUTE
|
|
Discovery, Biology and Risk of Inherited Variants in Glioma
|
1R01CA217105-01A1
|
$1,043,807
|
BONDY, MELISSA
|
BAYLOR COLLEGE OF MEDICINE
|
|
Breast CT: Final Steps to Translation
|
5R01CA181081-04
|
$559,655
|
BOONE, JOHN
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
The Structure, Function and Regulation of Eukaryotic DNA Replication Initiator Complexes
|
5R01CA030490-37
|
$610,461
|
BOTCHAN, MICHAEL
|
UNIVERSITY OF CALIFORNIA BERKELEY
|
|
Development of a versatile robotic radiation therapy system
|
5R44CA183390-03
|
$753,117
|
BOUCHER, SALIME
|
RADIABEAM TECHNOLOGIES, LLC
|
|
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
|
5R21CA216678-02
|
$212,063
|
BRADLEY, LINDA
|
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INST
|
|
Validation of biomarkers for early diagnosis and risk prediction of pancreatic neoplasms
|
5U01CA200466-03
|
$1,563,388
|
BRAND, RANDALL
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Electronic cigarette use in lung cancer patients
|
1K07CA215546-01A1
|
$138,887
|
BRASKY, THEODORE
|
OHIO STATE UNIVERSITY
|
|
Identification and targeting of mechanisms specific to glioma stem cells in glioblastoma
|
1R01CA214928-01A1
|
$368,965
|
BRAT, DANIEL
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Extracellular Vesicles (EVs) and Genes in the Biology and Therapy of Gliomas
|
5P01CA069246-21
|
$1,316,832
|
BREAKEFIELD, XANDRA
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Great Lakes New England Clinical Validation Center
|
5U01CA086400-18
|
$1,178,448
|
BRENNER, DEAN
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
A Genetic Toolbox for the Identification and Interrogation of Tumor Cells of Origin, Propagation, and Recurrence From Patient-derived Oncogenic Drivers
|
5R33CA202900-03
|
$418,127
|
BREUNIG, JOSHUA
|
CEDARS-SINAI MEDICAL CENTER
|
|
Cancer Immunotherapy Through Intratumoral Activation of Recall Responses
|
1F32CA224593-01
|
$58,654
|
BROWN, MICHAEL
|
DUKE UNIVERSITY
|
|
Effects of ATR-CHK1 inhibition on genome stability and cancer progression
|
5R01CA189743-04
|
$323,192
|
BROWN, ERIC
|
UNIVERSITY OF PENNSYLVANIA
|
|
Modulating signaling pathways in endothelial cells to abate leukemic progression.
|
5R01CA204308-03
|
|
BUTLER, JASON
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
|
Targeting Granzyme B to Separate GVH from GVL Responses
|
5R01CA184728-05
|
$353,419
|
CAO, XUEFANG
|
UNIVERSITY OF MARYLAND BALTIMORE
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|